Jonathan Fleming is Director at MEMORY PHARMACEUTICALS CORP (MEMY). They have made 1 open-market trade across 1 company since 2007, most recently 2013-12-06.
CIK 0001262294
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $550K since 2007, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MEMY | BUY | 2007-11-28 | 2007-11-30 | $0.55 | $550K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.